A mother who lost her son to a highly aggressive brain cancer has voiced strong support for a new research hub. Brain Tumour Research has unveiled a £2.6 million plan to establish a centre of excellence at the University of Nottingham, dedicated to advancing understanding and treatment of glioblastoma, the deadliest form of adult brain tumour. The charity aims to drive progress toward a cure that could spare other families from similar heartbreak.
Maggie Cullen of Boston spoke about her son Josh, who died of glioblastoma in October last year. She said, “If scientists and doctors can find a cure and stop any more mums from witnessing this horror, it would be nothing short of miraculous.” Josh, a 24-year-old aviation enthusiast who had hoped to move to Canada, was diagnosed with an aggressive brain tumour on Christmas Eve 2020.
When the diagnosis came back as glioblastoma, Maggie recalled feeling the sting of that word more than anything else. “I wished for any other term, just not glioblastoma.” The doctors gave Josh 12 to 18 months to live, and Maggie notes that, at 24, she would have expected him to surrender. In contrast, Josh battled on with remarkable resilience.
The Nottingham centre intends to combine artificial intelligence with cutting-edge MRI imaging to detect tumour recurrence earlier and tailor treatments. Principal Investigator Prof Ruman Rahman explained the long-term goal: to someday identify drugs for each patient using brain imaging, aiming to prevent recurrence of glioblastoma. He cautioned that this transformation won’t occur overnight and stressed the need for ongoing investment in brain tumour research to turn the cure aspiration into reality.
Maggie Cullen described the development as meaningful, a form of progress long overdue for brain tumour research and for the many families touched by the disease. Verity Phillips, a 35-year-old mother of four from Immingham who was diagnosed with glioblastoma in 2022 after a collapse, also welcomed the announcement. She shared that glioblastoma is brutal and that she, like many patients, initially faced a survival horizon of 12 to 18 months. Although she has surpassed those odds, she continues living with regular scans and a hopeful mindset, determined to be there for her children’s bedtime routines and everyday moments.
Phillips called the Nottingham project a beacon of hope for glioblastoma patients. She emphasized that while the tumour may not disappear, ongoing awareness and research are essential until a cure is found.
Listeners can access regional highlights on BBC Sounds, watch the latest Look North episode, or share a story they’d like covered. For mobile users, BBC News apps are available on iPhone, iPad, and Android devices for news updates.
